Page last updated: 2024-08-16

resveratrol and Dyskinesia Syndromes

resveratrol has been researched along with Dyskinesia Syndromes in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	3 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Lerner, PP; Lerner, V; Miodownik, C	1
Li, L; Shi, N; Zhu, C	1
Barbosa, NB; Busanello, A; Fachinetto, R; Pereira, RP; Peroza, LR; Prestes, Ade S; Rocha, JB; Sudati, JH; Wagner, C	1

Reviews

1 review(s) available for resveratrol and Dyskinesia Syndromes

Article	Year
Tardive dyskinesia (syndrome): Current concept and modern approaches to its management. Psychiatry and clinical neurosciences, 2015, Volume: 69, Issue:6 Topics: Adrenergic beta-Antagonists; Adrenergic Uptake Inhibitors; alpha-Tocopherol; Amantadine; Anticonvulsants; Antioxidants; Antipsychotic Agents; Clonazepam; Dopamine Agents; Drugs, Chinese Herbal; Fatty Acids, Omega-3; Ginkgo biloba; Humans; Isoleucine; Isoxazoles; Leucine; Levetiracetam; Melatonin; Movement Disorders; Nootropic Agents; Piracetam; Plant Extracts; Propranolol; Pyridoxine; Resveratrol; Stilbenes; Tetrabenazine; Valine; Vitamins; Zonisamide	2015

Article

Year

Tardive dyskinesia (syndrome): Current concept and modern approaches to its management.

Psychiatry and clinical neurosciences, 2015, Volume: 69, Issue:6

Topics: Adrenergic beta-Antagonists; Adrenergic Uptake Inhibitors; alpha-Tocopherol; Amantadine; Anticonvulsants; Antioxidants; Antipsychotic Agents; Clonazepam; Dopamine Agents; Drugs, Chinese Herbal; Fatty Acids, Omega-3; Ginkgo biloba; Humans; Isoleucine; Isoxazoles; Leucine; Levetiracetam; Melatonin; Movement Disorders; Nootropic Agents; Piracetam; Plant Extracts; Propranolol; Pyridoxine; Resveratrol; Stilbenes; Tetrabenazine; Valine; Vitamins; Zonisamide

2015

Other Studies

2 other study(ies) available for resveratrol and Dyskinesia Syndromes

Article	Year
Rehabilitation Training and Resveratrol Improve the Recovery of Neurological and Motor Function in Rats after Cerebral Ischemic Injury through the Sirt1 Signaling Pathway. BioMed research international, 2016, Volume: 2016 Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Brain Ischemia; Combined Modality Therapy; Exercise Therapy; Male; Movement Disorders; Neurological Rehabilitation; Rats; Rats, Sprague-Dawley; Recovery of Function; Resveratrol; Sirtuin 1; Stilbenes; Treatment Outcome	2016
Resveratrol reduces vacuous chewing movements induced by acute treatment with fluphenazine. Pharmacology, biochemistry, and behavior, 2012, Volume: 101, Issue:2 Topics: Animals; Fluphenazine; Male; Mastication; Movement Disorders; Neuroprotective Agents; Rats; Rats, Wistar; Resveratrol; Stilbenes	2012

Article

Year

Rehabilitation Training and Resveratrol Improve the Recovery of Neurological and Motor Function in Rats after Cerebral Ischemic Injury through the Sirt1 Signaling Pathway.

BioMed research international, 2016, Volume: 2016

Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Brain Ischemia; Combined Modality Therapy; Exercise Therapy; Male; Movement Disorders; Neurological Rehabilitation; Rats; Rats, Sprague-Dawley; Recovery of Function; Resveratrol; Sirtuin 1; Stilbenes; Treatment Outcome

2016

Resveratrol reduces vacuous chewing movements induced by acute treatment with fluphenazine.

Pharmacology, biochemistry, and behavior, 2012, Volume: 101, Issue:2

Topics: Animals; Fluphenazine; Male; Mastication; Movement Disorders; Neuroprotective Agents; Rats; Rats, Wistar; Resveratrol; Stilbenes

2012